Inflammatory macrophages reprogram to immunosuppression by reducing mitochondrial translation
Abstract Acute inflammation can either resolve through immunosuppression or persist, leading to chronic inflammation. These transitions are driven by distinct molecular and metabolic reprogramming of immune cells. The anti-diabetic drug Metformin inhibits acute and chronic inflammation through mecha...
Main Authors: | Marlies Cortés, Agnese Brischetto, M. C. Martinez-Campanario, Chiara Ninfali, Verónica Domínguez, Sara Fernández, Raquel Celis, Anna Esteve-Codina, Juan J. Lozano, Julia Sidorova, Gloria Garrabou, Anna-Maria Siegert, Carlos Enrich, Belén Pintado, Manuel Morales-Ruiz, Pedro Castro, Juan D. Cañete, Antonio Postigo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-42277-4 |
Similar Items
-
The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2
by: Chiara Ninfali, et al.
Published: (2023-10-01) -
Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation
by: M. C. Martinez-Campanario, et al.
Published: (2023-12-01) -
ZEB1 protects skeletal muscle from damage and is required for its regeneration
by: Laura Siles, et al.
Published: (2019-03-01) -
Metabolic reprogramming in the immunosuppression of tumor-associated macrophages
by: Ying Wang, et al.
Published: (2022-10-01) -
Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms
by: Filippo Torrisi, et al.
Published: (2023-01-01)